Category Archives: Oncology

What is Justice Ruth Bader Ginsburg’s prognosis?

Posted on September 18, 2019 by admin

December 21, 2018- by Steven E. Greer, MD Supreme Court Justice Ruth Bader Ginsburd underwent surgery at Memorial Sloan Kettering

Posted in - Opinion, Cardiac surgery, Memorial Sloan-Kettering, Oncology | Leave a comment

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

Posted on March 20, 2019 by admin

 April 21, 2015- By Steven E. Greer, MD Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals,

Posted in - Policy, Cardiology, Harvard, Neurology, Oncology | Leave a comment

Once again, daily aspirin is shown to be deadly rather than beneficial

Posted on February 15, 2019 by admin

September 16, 2018- by Steven E. Greer, MD The Healthcare Channel has been pounding the table for many years pushing back against the drug

Posted in - NEJM, - Pharma, Cardiac surgery, Cardiology, Gastroenterology and liver, Geriatrics, Internal Medicine, Neurology, Neurosurgery, Oncology, Vascular Surgery | Leave a comment

Review of immunotherapy and targeted therapy

Posted on January 5, 2019 by admin

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

CBS News not happy at all that cancer warning added to coffee

Posted on October 1, 2018 by admin

March 29, 2018- by Steven E. Greer, MD I have been critical of CBS News for years because they have been in bed with the coffee industry,

Posted in - Opinion, - Policy, Congress, Oncology | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

Posted on September 1, 2018 by admin

March 19, 2013- Interviewed by Steven E. Greer, MD The upcoming ASCO meeting will be dominated by numerous presentations relating to new

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Bending the cost curve of cancer care

Posted on February 26, 2018 by admin

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

Posted on February 23, 2018 by admin

November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

Hormone replacement therapy is safe and effective after all

Posted on January 31, 2018 by admin

November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

Increasing rates of double mastectomies in early stage breast cancer

Posted on January 15, 2018 by admin

November 22, 2013- Interviewed by Steven E. Greer, MD David P. Winchester MD, Medical Director of Cancer Programs for the American College of Surgeons,

Posted in - Policy, Oncology, Plastic surgery | Leave a comment

What 1982’s Blade Runner got right about 2019

Posted on January 4, 2018 by admin

September 3, 2017- by Steven E. Greer, MD I watched again the 1982 classic Blade Runner. Directed by Ridley Scott and starring Harrison Ford,

Posted in - Opinion, - Reviews, books, devices, Genetics, Geriatrics, Obstetrics and Gynecology, Oncology, Ophthalmology | Leave a comment

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Posted on January 3, 2018 by admin

January 12, 2017- Interviewed by Steven E. Greer, MD Jonathan Strosberg, MD of

Posted in - NEJM, Oncology | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

Posted on January 2, 2018 by admin

June 22, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma,

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The 23andMe home genetics test kit controversy

Posted on November 26, 2017 by admin

December 19, 2013- Interviewed by Steven E. Greer,  MD

Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry | Leave a comment

Interview with the CEO of Galena Biopharma about cancer vaccines

Posted on November 5, 2017 by admin

February 8, 2016- Interviewed by Steven E. Greer, MD

Posted in - Biotech, Oncology | Leave a comment

CheckMate 026: Why did Opdivo (nivolumab) fail in NSCLC?

Posted on September 9, 2017 by admin

September 1, 2016- Interviewed by Steven E. Greer, MD In the wake of the news-making failure of CheckMate 026 of Bristol-Myers Squibb’s Opdivo (nivolumab) fail in

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Ibrance (palbociclib) to treat advanced breast cancer

Posted on November 1, 2016 by admin

November 28, 2016- Interviewed by Steven E. Greer, MD We interviewed Richard Finn,

Posted in - Biotech, - NEJM, - Pharma, Oncology, UCLA | Leave a comment

The telomerase inhibitor Imetelstat developed by Geron

Posted on February 5, 2016 by admin

September 9, 2015-

Posted in - Biotech, - NEJM, Oncology | Leave a comment

Exclusive: CEO of Komen for the Cure never stepped down as announced in 2012

Posted on June 6, 2013 by admin

June 6, 2013- By Steven E. Greer, MD The breast cancer research foundation Komen for the Cure, founded by Nancy Brinker, got into hot water in 2012

Posted in - Policy, Oncology | Leave a comment

anti-PD1 and anti-PD-L1 drugs treating NSCLC

Posted on March 26, 2013 by admin

March 26, 2013 Interviewed By Steven E. Greer, MD

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment